Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Glaukos (GKOS) EBT (2016 - 2025)

Glaukos (GKOS) has disclosed EBT for 12 consecutive years, with -$144.4 million as the latest value for Q4 2025.

  • On a quarterly basis, EBT fell 302.02% to -$144.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$197.6 million, a 33.69% decrease, with the full-year FY2025 number at -$197.6 million, down 33.69% from a year prior.
  • EBT was -$144.4 million for Q4 2025 at Glaukos, down from -$16.0 million in the prior quarter.
  • In the past five years, EBT ranged from a high of $101.5 million in Q4 2023 to a low of -$144.4 million in Q4 2025.
  • A 5-year average of -$24.5 million and a median of -$25.8 million in 2021 define the central range for EBT.
  • Biggest YoY gain for EBT was 425.68% in 2023; the steepest drop was 700.12% in 2023.
  • Glaukos' EBT stood at -$24.3 million in 2021, then fell by 28.04% to -$31.2 million in 2022, then skyrocketed by 425.68% to $101.5 million in 2023, then crashed by 135.39% to -$35.9 million in 2024, then tumbled by 302.02% to -$144.4 million in 2025.
  • Per Business Quant, the three most recent readings for GKOS's EBT are -$144.4 million (Q4 2025), -$16.0 million (Q3 2025), and -$19.4 million (Q2 2025).